See also this year's filing and all EDGAR filings for this company.
PDF Report 0001404644_2018_Neoleukin_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001404644')"} |
Graph
Absolute values for 0001404644, Neoleukin Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 108,825,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 905,000 |
| 3 | remainder_Assets | 599,000 |
| 4 | LiabilitiesCurrent | 10,956,000 |
| 5 | LiabilitiesNoncurrent | 486,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,852,000 |
| 9 | ResearchAndDevelopmentExpense | 36,267,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 936,000 |
| 13 | remainder_ComprehensiveNetIncome | 99,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 110,329,000 |
| 1 | Liabilities | 11,442,000 |
| 2 | Expenses | 51,119,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 98,887,000 |
| 5 | NetIncome | -50,183,000 |
| 6 | ComprehensiveNetIncome | -50,133,500 |
| 7 | BaseVar | 86,962,500 |
| 8 | EconomicCapitalRatio | 1.97 |
Edgar->Model Mapping
Feature Distribution
Change over Time
